Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Sell
825
-908
-52% -$311K 0.08% 136
2026
Q1
$610K Sell
1,733
-217
-11% -$77.4K 0.14% 108
2025
Q4
$672K Sell
1,950
-101
-5% -$32K 0.14% 103
2025
Q3
$600K Sell
2,051
-384
-16% -$111K 0.13% 109
2025
Q2
$680K Sell
2,435
-68
-3% -$19.3K 0.18% 100
2025
Q1
$780K Sell
2,503
-241
-9% -$71.2K 0.24% 83
2024
Q4
$715K Buy
2,744
+493
+22% +$146K 0.2% 91
2024
Q3
$725K Buy
2,251
+43
+2% +$14.1K 0.21% 82
2024
Q2
$690K Buy
2,208
+147
+7% +$43.2K 0.21% 81
2024
Q1
$586K Buy
2,061
+23
+1% +$6.73K 0.17% 102
2023
Q4
$587K Sell
2,038
-83
-4% -$22.6K 0.18% 92
2023
Q3
$570K Buy
2,121
+73
+4% +$18.2K 0.19% 91
2023
Q2
$455K Buy
2,048
+206
+11% +$47.8K 0.16% 99
2023
Q1
$446K Buy
1,842
+42
+2% +$10.3K 0.15% 101
2022
Q4
$473K Buy
1,800
+14
+0.8% +$3.75K 0.18% 97
2022
Q3
$438K Buy
+1,786
New +$433K 0.2% 91
2022
Q2
Sell
-1,049
Closed -$264K 151
2022
Q1
$264K Buy
1,049
+13
+1% +$2.99K 0.13% 126
2021
Q4
$233K Buy
+1,036
New +$219K 0.1% 146

Other funds holding AMGN

Apeiron RIA's AMGN Position: Q2 2026 in Review

Apeiron RIA reduced its Amgen (AMGN) stake by 52% in Q2 2026, selling an estimated $311K and leaving 825 shares worth $299K. The position accounts for 0.08% of the portfolio, ranked #136.

Apeiron RIA first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $780K in Q1 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Apeiron RIA held 825 shares of Amgen worth $299K as of Q2 2026.
  • Apeiron RIA sold 908 Amgen shares in Q2 2026, an estimated $311K.
  • Amgen made up 0.08% of Apeiron RIA's portfolio in Q2 2026, its #136 holding.
  • Apeiron RIA first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Apeiron RIA's Amgen position peaked at $780K in Q1 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Apeiron RIA's 13F filing for Q2 2026, filed 16 Jul 2026.